<SEC-DOCUMENT>0001104659-24-119763-index.html : 20241115 <SEC-HEADER>0001104659-24-119763.hdr.sgml : 20241115 <ACCEPTANCE-DATETIME>20241115170115 ACCESSION NUMBER: 0001104659-24-119763 CONFORMED SUBMISSION TYPE: F-1 PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20241115 DATE AS OF CHANGE: 20241115 FILER: COMPANY DATA: COMPANY CONFORMED NAME: XORTX Therapeutics Inc. CENTRAL INDEX KEY: 0001729214 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: F-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-283275 FILM NUMBER: 241468738 BUSINESS ADDRESS: STREET 1: SUITE 2400 - 745 THURLOW STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 0C5 BUSINESS PHONE: 403-607-2621 MAIL ADDRESS: STREET 1: SUITE 2400 - 745 THURLOW STREET CITY: VANCOUVER STATE: A1 ZIP: V6E 0C5 </SEC-HEADER> <DOCUMENT> <TYPE>F-1 <SEQUENCE>1 <FILENAME>tm2428455-1_f1.htm <DESCRIPTION>F-1 <TEXT> Document 1 - file: tm2428455-1_f1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>tm2428455d2_ex5-1.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: tm2428455d2_ex5-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>tm2428455d2_ex23-1.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: tm2428455d2_ex23-1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>4 <FILENAME>tm2428455d2_ex-filingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 4 - file: tm2428455d2_ex-filingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>tm2428455d2_ex5-1img001.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 5 - file: tm2428455d2_ex5-1img001.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>tm2428455d2_ex5-1img002.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: tm2428455d2_ex5-1img002.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>lg_xortxtherapeutics-4clr.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: lg_xortxtherapeutics-4clr.jpg
</DOCUMENT> </SEC-DOCUMENT>